CelAgace™ OraRinse (CAOR) Pilot Clinical Study for Management of Candidiasis Associated With Grade 0-II Mucositis
CelAgace™ OraRinse (silver citrate complex and acemannan) Solution is planned to be evaluated for safety and effectiveness as a potential treatment for candidiasis, a yeast infection, commonly known as thrush, which is associated with mouth sores.
100 项与 CelaCare Technologies 相关的临床结果
0 项与 CelaCare Technologies 相关的专利(医药)
100 项与 CelaCare Technologies 相关的药物交易
100 项与 CelaCare Technologies 相关的转化医学